tradingkey.logo

瑞思迈

RMD
查看详细走势图
257.610USD
-0.110-0.04%
收盘 01/29, 16:00美东报价延迟15分钟
37.60B总市值
26.26市盈率 TTM

瑞思迈

257.610
-0.110-0.04%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.04%

5天

+0.89%

1月

+6.08%

6月

-7.23%

今年开始到现在

+6.95%

1年

+1.88%

查看详细走势图

TradingKey 瑞思迈股票评分

单位: USD 更新时间: 2026-01-29

操作建议

瑞思迈当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名8/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价292.76。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

瑞思迈评分

相关信息

行业排名
8 / 205
全市场排名
67 / 4540
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

瑞思迈亮点

亮点风险
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
业绩高增长
公司营业收入稳步增长,连续3年增长21.86%
利润高增长
公司净利润处于行业前列,最新年度总收入5.15B美元
高分红
公司属于高分红公司,最新股息支付率22.19%
稳定分红
公司5年内连续分红,最新股息支付率22.19%
估值低估
公司最新PE估值26.26,处于3年历史低位
机构减仓
最新机构持股95.97M股,环比减少1.42%
ETHSX持仓
明星投资者ETHSX持仓,最新持仓市值17.10K

分析师目标

根据 21 位分析师
买入
评级
292.763
目标均价
+14.58%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

瑞思迈简介

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
公司代码RMD
公司瑞思迈
CEOFarrell (Michael J)
网址https://www.resmed.com/
KeyAI